Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
MADRID - Some volunteers have quit Johnson & Johnson’s COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca’s trial, the Spanish programme’s lead investigator told Reuters on Tuesday.
“Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying, these types of questions,” Borobia said.AstraZeneca’s COVID-19 vaccine trials were placed on hold worldwide on Sept. 6 after a serious side effect was reported in one volunteer in Britain.
Trials are also being carried out in the Netherlands and Germany, taking the total number of participants in all three countries to 550. If some doses and schedules generate considerable amounts of antibodies, an intermediate Phase III analysis could be conducted before the end of Phase II, Borobia said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare, investigator saysSome volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
Read more »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Read more »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Read more »
WHO praises AstraZeneca COVID-19 vaccine trial pauseA World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.
Read more »
AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Read more »
Trump administration has not paid USPS for COVID-19 postcards featuring Trump's nameThe bill for the postcards sent to 138 million residential addresses has still not been paid, a USPS spokesperson said.
Read more »